{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:55:05Z","timestamp":1794434105261,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07763-z","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:38:18Z","timestamp":1741066698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-7336","authenticated-orcid":false,"given":"Julia","family":"Revuelta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Rusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-3824","authenticated-orcid":false,"given":"Clara","family":"Frances-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Trapero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Calvo","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-0977","authenticated-orcid":false,"given":"Ana-Bel\u00e9n","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-9179","authenticated-orcid":false,"given":"Alfonso","family":"Guti\u00e9rrez-Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acsah","family":"Konuparamban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"G\u00f3mez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-4044","authenticated-orcid":false,"given":"Alicia","family":"Forcada-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-6821","authenticated-orcid":false,"given":"Mar\u00eda Luisa","family":"L\u00f3pez-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Avil\u00e9s-Al\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IBV-Covid19-Pipeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gougeard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Marco-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmol","family":"Adhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Pilar","family":"Hern\u00e1ndez-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Del Ca\u00f1o-Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gozalbo-Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ram\u00f3n-Maiques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5304-1795","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Ll\u00e1cer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-9838","authenticated-orcid":false,"given":"Jordi","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-3613","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Mart\u00edn Acebes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-4611","authenticated-orcid":false,"given":"Ron","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-7538","authenticated-orcid":false,"given":"Alfonso","family":"Fern\u00e1ndez-Mayoralas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"7763_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/pathogens10070827","volume":"10","author":"W.-H Wang","year":"2021","unstructured":"Wang, W.-H., Thitithanyanont, A., Urbina, A. N. & Wang, S.-F. Emerging and re-emerging diseases. Pathogens 10, 827 (2021).","journal-title":"Pathogens"},{"key":"7763_CR2","doi-asserted-by":"crossref","unstructured":"Delardas, O., Kechagias, K. S., Pontikos, P. N. & Giannos, P. Socio-economic impacts and challenges of the coronavirus pandemic (COVID-19): an updated review. Sustainability 14, 9699 (2022).","DOI":"10.3390\/su14159699"},{"key":"7763_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43769-z","volume":"14","author":"A. X Han","year":"2023","unstructured":"Han, A. X. et al. Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs. Nat. Commun. 14, 7981 (2023).","journal-title":"Nat. Commun."},{"key":"7763_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","volume":"83","author":"D Xu","year":"2014","unstructured":"Xu, D. & Esko, J. D. Demystifying heparan sulfate\u2013protein interactions. Annu. Rev. Biochem. 83, 129\u2013157 (2014).","journal-title":"Annu. Rev. Biochem."},{"key":"7763_CR5","doi-asserted-by":"crossref","unstructured":"Li, J.-P. & Kusche-Gullberg, M. Chapter Six - Heparan Sulfate: Biosynthesis, Structure, and Function. in Proc. International Review of Cell and Molecular Biology (ed. Jeon, K. W. B. T.-I. R. of C. and M. B.) 215\u2013273 (Academic Press, 2016).","DOI":"10.1016\/bs.ircmb.2016.02.009"},{"key":"7763_CR6","doi-asserted-by":"publisher","unstructured":"Bedini, E., Corsaro, M. M., Fern\u00e1ndez-Mayoralas, A. & Iadonisi, A. Chondroitin, dermatan, heparan, and keratan sulfate: structure and functions BT - extracellular sugar-based biopolymers matrices. in (eds. Cohen, E. & Merzendorfer, H.) 187\u2013233 (Springer International Publishing, Cham, 2019). https:\/\/doi.org\/10.1007\/978-3-030-12919-4_5.","DOI":"10.1007\/978-3-030-12919-4_5"},{"key":"7763_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/brv.12034","volume":"88","author":"E Kamhi","year":"2013","unstructured":"Kamhi, E., Joo, E. J., Dordick, J. S. & Linhardt, R. J. Glycosaminoglycans in infectious disease. Biol. Rev. 88, 928\u2013943 (2013).","journal-title":"Biol. Rev."},{"key":"7763_CR8","doi-asserted-by":"crossref","unstructured":"Bauer, S., Zhang, F. & Linhardt, R. J. Implications of glycosaminoglycans on viral zoonotic diseases. Diseases 9, 85 (2021).","DOI":"10.3390\/diseases9040085"},{"key":"7763_CR9","doi-asserted-by":"crossref","unstructured":"Cagno, V., Tseligka, E. D., Jones, S. T. & Tapparel, C. Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses 11, 596 (2019).","DOI":"10.3390\/v11070596"},{"key":"7763_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41453-w","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation. Nat. Commun. 14, 5777 (2023).","journal-title":"Nat. Commun."},{"key":"7763_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-020-00222-5","volume":"6","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell Discov. 6, 80 (2020).","journal-title":"Cell Discov."},{"key":"7763_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102439","volume":"76","author":"F. L Kearns","year":"2022","unstructured":"Kearns, F. L. et al. Spike-heparan sulfate interactions in SARS-CoV-2 infection. Curr. Opin. Struct. Biol. 76, 102439 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"7763_CR13","doi-asserted-by":"publisher","unstructured":"Alotaibi, F. S. et al. Interactions of proteins with heparan sulfate. Essays Biochem. EBC20230093 https:\/\/doi.org\/10.1042\/EBC20230093 (2024).","DOI":"10.1042\/EBC20230093"},{"key":"7763_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/acscentsci.1c00010","volume":"7","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2. ACS Cent. Sci. 7, 1009\u20131018 (2021).","journal-title":"ACS Cent. Sci."},{"key":"7763_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"T. M Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 Infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043\u20131057.e15 (2020).","journal-title":"Cell"},{"key":"7763_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41579-019-0149-x","volume":"17","author":"M. B Battles","year":"2019","unstructured":"Battles, M. B. & McLellan, J. S. Respiratory syncytial virus entry and how to block it. Nat. Rev. Microbiol. 17, 233\u2013245 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"7763_CR17","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/JVI.74.14.6442-6447.2000","volume":"74","author":"S. A Feldman","year":"2000","unstructured":"Feldman, S. A., Audet, S. & Beeler, J. A. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J. Virol. 74, 6442\u20136447 (2000).","journal-title":"J. Virol."},{"key":"7763_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nm0897-866","volume":"3","author":"Y Chen","year":"1997","unstructured":"Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866\u2013871 (1997).","journal-title":"Nat. Med."},{"key":"7763_CR19","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1128\/JVI.75.3.1565-1570.2001","volume":"75","author":"T Giroglou","year":"2001","unstructured":"Giroglou, T., Florin, L., Sch\u00e4fer, F., Streeck, R. E. & Sapp, M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75, 1565\u20131570 (2001).","journal-title":"J. Virol."},{"key":"7763_CR20","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1128\/JVI.01621-12","volume":"87","author":"B Salvador","year":"2013","unstructured":"Salvador, B. et al. Filoviruses utilize glycosaminoglycans for their attachment to target cells. J. Virol. 87, 3295\u20133304 (2013).","journal-title":"J. Virol."},{"key":"7763_CR21","doi-asserted-by":"publisher","first-page":"9534","DOI":"10.1021\/jacs.7b01399","volume":"139","author":"C Zong","year":"2017","unstructured":"Zong, C. et al. Heparan sulfate microarray reveals that heparan sulfate\u2013protein binding exhibits different ligand requirements. J. Am. Chem. Soc. 139, 9534\u20139543 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"7763_CR22","doi-asserted-by":"publisher","first-page":"118526","DOI":"10.1016\/j.carbpol.2021.118526","volume":"272","author":"W Lu","year":"2021","unstructured":"Lu, W., Yang, Z., Chen, J., Wang, D. & Zhang, Y. Recent advances in antiviral activities and potential mechanisms of sulfated polysaccharides. Carbohydr. Polym. 272, 118526 (2021).","journal-title":"Carbohydr. Polym."},{"key":"7763_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119551","volume":"291","author":"B Pradhan","year":"2022","unstructured":"Pradhan, B. et al. A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections. Carbohydr. Polym. 291, 119551 (2022).","journal-title":"Carbohydr. Polym."},{"key":"7763_CR24","doi-asserted-by":"crossref","unstructured":"Figueroa, J. M. et al. Efficacy of a nasal spray containing iota-carrageenan in the postexposure prophylaxis of covid-19 in hospital personnel dedicated to patients care with covid-19 disease. Int. J. Gen. Med. 14, 6277\u20136286 (2021).","DOI":"10.2147\/IJGM.S328486"},{"key":"7763_CR25","doi-asserted-by":"crossref","unstructured":"Ray, B. et al. Antiviral strategies using natural source-derived sulfated polysaccharides in the light of the covid-19 pandemic and major human pathogenic viruses. Viruses 14, 35 (2022).","DOI":"10.3390\/v14010035"},{"key":"7763_CR26","doi-asserted-by":"publisher","first-page":"e218 LP","DOI":"10.7861\/clinmed.2020-0351","volume":"20","author":"C Conzelmann","year":"2020","unstructured":"Conzelmann, C. et al. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19. Clin. Med. 20, e218 LP\u2013e218221 (2020).","journal-title":"Clin. Med."},{"key":"7763_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10557-021-07251-6","volume":"37","author":"A Vitiello","year":"2023","unstructured":"Vitiello, A. & Ferrara, F. Low molecular weight heparin, anti-inflammatory\/immunoregulatory and antiviral effects, a short update. Cardiovasc. Drugs Ther. 37, 277\u2013281 (2023).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"7763_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99404-8","volume":"11","author":"K Pyr\u0107","year":"2021","unstructured":"Pyr\u0107, K. et al. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray. Sci. Rep. 11, 20012 (2021).","journal-title":"Sci. Rep."},{"key":"7763_CR29","doi-asserted-by":"publisher","first-page":"31714","DOI":"10.1021\/acsomega.3c02143","volume":"8","author":"Z. E. D Cele","year":"2023","unstructured":"Cele, Z. E. D. et al. Cationic chitosan derivatives for the inactivation of HIV-1 and SARS-CoV-2 enveloped viruses. ACS Omega 8, 31714\u201331724 (2023).","journal-title":"ACS Omega"},{"key":"7763_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/jam.15202","volume":"132","author":"N Jaber","year":"2022","unstructured":"Jaber, N. et al. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19. J. Appl. Microbiol. 132, 41\u201358 (2022).","journal-title":"J. Appl. Microbiol."},{"key":"7763_CR31","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1039\/D1MH00728A","volume":"8","author":"J Revuelta","year":"2021","unstructured":"Revuelta, J. et al. Heparanized chitosans: towards the third generation of chitinous biomaterials. Mater. Horiz. 8, 2596\u20132614 (2021).","journal-title":"Mater. Horiz."},{"key":"7763_CR32","doi-asserted-by":"publisher","first-page":"25534","DOI":"10.1021\/acsami.0c03074","volume":"12","author":"J Revuelta","year":"2020","unstructured":"Revuelta, J. et al. Unraveling the structural landscape of chitosan-based heparan sulfate mimics binding to growth factors: deciphering structural determinants for optimal activity. ACS Appl. Mater. Interfaces 12, 25534\u201325545 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"7763_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.carbpol.2018.03.036","volume":"191","author":"E Doncel-P\u00e9rez","year":"2018","unstructured":"Doncel-P\u00e9rez, E. et al. Synthesis, physicochemical characterization and biological evaluation of chitosan sulfate as heparan sulfate mimics. Carbohydr. Polym. 191, 225\u2013233 (2018).","journal-title":"Carbohydr. Polym."},{"key":"7763_CR34","doi-asserted-by":"publisher","unstructured":"Junceda-Mena, I., Garc\u00eda-Junceda, E. & Revuelta, J. From the problem to the solution: chitosan valorization cycle. Carbohydr. Polym. 309, 120674 https:\/\/doi.org\/10.1016\/j.carbpol.2023.120674 (2023).","DOI":"10.1016\/j.carbpol.2023.120674"},{"key":"7763_CR35","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1002\/asia.201601041","volume":"11","author":"L. C. R Carvalho","year":"2016","unstructured":"Carvalho, L. C. R., Queda, F., Santos, C. V. A. & Marques, M. M. B. Selective modification of chitin and chitosan: en route to tailored oligosaccharides. Chem. Asian J. 11, 3468\u20133481 (2016).","journal-title":"Chem. Asian J."},{"key":"7763_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acscentsci.1c01293","volume":"8","author":"S. E Guimond","year":"2022","unstructured":"Guimond, S. E. et al. Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike\u2013ACE2 interaction. ACS Cent. Sci. 8, 527\u2013545 (2022).","journal-title":"ACS Cent. Sci."},{"key":"7763_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax9318","volume":"6","author":"S. T Jones","year":"2024","unstructured":"Jones, S. T. et al. Modified cyclodextrins as broad-spectrum antivirals. Sci. Adv. 6, eaax9318 (2024).","journal-title":"Sci. Adv."},{"key":"7763_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2023.03.059","volume":"357","author":"R Heida","year":"2023","unstructured":"Heida, R. et al. Development of an inhalable antiviral powder formulation against respiratory syncytial virus. J. Control. Release 357, 264\u2013273 (2023).","journal-title":"J. Control. Release"},{"key":"7763_CR39","doi-asserted-by":"crossref","unstructured":"Gargantilla, M. et al. C-2 Thiophenyl tryptophan trimers inhibit cellular entry of SARS-CoV-2 through interaction with the viral spike (S) Protein. J. Med. Chem. 66, (2023).","DOI":"10.1021\/acs.jmedchem.3c00576"},{"key":"7763_CR40","doi-asserted-by":"publisher","unstructured":"Hallak, L. K., Kwilas, S. A. & Peeples, M. E. Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate bt - glycovirology protocols. in (ed. Sugrue, R. J.) 15\u201334. https:\/\/doi.org\/10.1007\/978-1-59745-393-6_2 (Humana Press, Totowa, NJ, 2007).","DOI":"10.1007\/978-1-59745-393-6_2"},{"key":"7763_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","volume":"8","author":"S Beaucourt","year":"2014","unstructured":"Beaucourt, S. & Vignuzzi, M. Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance. Curr. Opin. Virol. 8, 10\u201315 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"7763_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100681","volume":"23","author":"C Nie","year":"2022","unstructured":"Nie, C. et al. Charge matters: mutations in omicron variant favor binding to cells. ChemBioChem 23, e202100681 (2022).","journal-title":"ChemBioChem"},{"key":"7763_CR43","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhang, J. & Wang, J. Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: a review and mechanistic hypothesis. Front. Public Health 10, 952916 (2022).","DOI":"10.3389\/fpubh.2022.952916"},{"key":"7763_CR44","doi-asserted-by":"publisher","unstructured":"Gelbach, A. L. et al. Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants. Front. Mol. Biosci. 9, https:\/\/doi.org\/10.3389\/fmolb.2022.912887 (2022).","DOI":"10.3389\/fmolb.2022.912887"},{"key":"7763_CR45","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"C.-L Hsieh","year":"2020","unstructured":"Hsieh, C.-L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"7763_CR46","doi-asserted-by":"crossref","unstructured":"Petrov, S. A., Yusubov, M. S., Beloglazkina, E. K. & Nenajdenko, V. G. Synthesis of radioiodinated compounds. Classical approaches and achievements of recent years. Int. J. Mol. Sci. 23, 13789 (2022).","DOI":"10.3390\/ijms232213789"},{"key":"7763_CR47","doi-asserted-by":"publisher","first-page":"115882","DOI":"10.1016\/j.biopha.2023.115882","volume":"169","author":"P Botella-Asunci\u00f3n","year":"2023","unstructured":"Botella-Asunci\u00f3n, P. et al. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity. Biomed. Pharmacother. 169, 115882 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"7763_CR48","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1128\/AAC.49.11.4700-4707.2005","volume":"49","author":"M Asunci\u00f3n","year":"2005","unstructured":"Asunci\u00f3n, M. et al. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the rsv murine model: time versus potency. Antimicrob. Agents Chemother. 49, 4700\u20134707 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7763_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1743-422X-7-250","volume":"7","author":"R Bannister","year":"2010","unstructured":"Bannister, R. et al. Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease. Virol. J. 7, 250 (2010).","journal-title":"Virol. J."},{"key":"7763_CR50","doi-asserted-by":"publisher","first-page":"e51485","DOI":"10.1371\/journal.pone.0051485","volume":"7","author":"H Caidi","year":"2012","unstructured":"Caidi, H., Harcourt, J. L., Tripp, R. A., Anderson, L. J. & Haynes, L. M. Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB\/c Mice. PLoS ONE 7, e51485 (2012).","journal-title":"PLoS ONE"},{"key":"7763_CR51","doi-asserted-by":"crossref","unstructured":"Liu, J. & Pedersen, L. C. Anticoagulant heparan sulfate: Structural specificity and biosynthesis. Appl. Microbiol. Biotech. 74, 263\u2013272 (2007).","DOI":"10.1007\/s00253-006-0722-x"},{"key":"7763_CR52","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Preparation, characterization and in vitro anticoagulant activity of highly sulfated chitosan. Int. J. Biol. Macromol. 52, (2013).","DOI":"10.1016\/j.ijbiomac.2012.09.027"},{"key":"7763_CR53","doi-asserted-by":"publisher","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","volume":"376","author":"A. R. Y. Bin Lee","year":"2022","unstructured":"Lee, A. R. Y. Bin et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 376, e068632 (2022).","journal-title":"BMJ"},{"key":"7763_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12979-017-0107-2","volume":"15","author":"B Weinberger","year":"2018","unstructured":"Weinberger, B. Vaccines for the elderly: current use and future challenges. Immun. Aging 15, 3 (2018).","journal-title":"Immun. Aging"},{"key":"7763_CR55","doi-asserted-by":"publisher","first-page":"105834","DOI":"10.1016\/j.antiviral.2024.105834","volume":"224","author":"E. H Tam","year":"2024","unstructured":"Tam, E. H., Peng, Y., Cheah, M. X. Y., Yan, C. & Xiao, T. Neutralizing antibodies to block viral entry and for identification of entry inhibitors. Antivir. Res. 224, 105834 (2024).","journal-title":"Antivir. Res."},{"key":"7763_CR56","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","volume":"21","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo, G., Correia, B., Fenwick, C., Joo, V. S. & Perez, L. Antibodies to combat viral infections: development strategies and progress. Nat. Rev. Drug Discov. 21, 676\u2013696 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7763_CR57","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","volume":"172","author":"D. R Tompa","year":"2021","unstructured":"Tompa, D. R., Immanuel, A., Srikanth, S. & Kadhirvel, S. Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs. Int. J. Biol. Macromol. 172, 524\u2013541 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"7763_CR58","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1586\/eri.12.104","volume":"10","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y. & Simmons, G. Development of novel entry inhibitors targeting emerging viruses. Expert Rev. Anti Infect. Ther. 10, 1129\u20131138 (2012).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"7763_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","volume":"74","author":"R. Q Cron","year":"2023","unstructured":"Cron, R. Q., Goyal, G. & Chatham, G. G. Cytokine Storm Syndrome. Annu. Rev. Med. 74, 321\u2013337 (2023).","journal-title":"Annu. Rev. Med."},{"key":"7763_CR60","doi-asserted-by":"crossref","unstructured":"Braz-de-Melo, H. A. et al. The use of the anticoagulant heparin and corticosteroid dexamethasone as prominent treatments for COVID-19. Front. Med. 8, 615333 (2021).","DOI":"10.3389\/fmed.2021.615333"},{"key":"7763_CR61","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cts.12880","volume":"13","author":"C Shi","year":"2020","unstructured":"Shi, C. et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study. Clin. Transl. Sci. 13, 1087\u20131095 (2020).","journal-title":"Clin. Transl. Sci."},{"key":"7763_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0008-6215(97)00117-1","volume":"302","author":"K. R Holme","year":"1997","unstructured":"Holme, K. R. & Perlin, A. S. Chitosan N-sulfate. A water-soluble polyelectrolyte. Carbohydr. Res. 302, 7\u201312 (1997).","journal-title":"Carbohydr. Res."},{"key":"7763_CR63","doi-asserted-by":"crossref","unstructured":"Latorre, V. & Geller, R. Identification of cytoplasmic chaperone networks relevant for respiratory syncytial virus replication. Front. Microbiol. 13, 880394 (2022).","DOI":"10.3389\/fmicb.2022.880394"},{"key":"7763_CR64","doi-asserted-by":"crossref","unstructured":"Saleh, M. C. et al. Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature 458, 346\u2013350 (2009).","DOI":"10.1038\/nature07712"},{"key":"7763_CR65","doi-asserted-by":"crossref","unstructured":"Casasnovas, J. M. et al. Nanobodies protecting from lethal SARS-CoV-2 infection target receptor binding epitopes preserved in virus variants other than omicron. Front. Immunol. 13, 863831 (2022).","DOI":"10.3389\/fimmu.2022.863831"},{"key":"7763_CR66","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Pulido, M. et al. Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses. Front. Immunol. 14, 1166725 (2023).","DOI":"10.3389\/fimmu.2023.1166725"},{"key":"7763_CR67","doi-asserted-by":"crossref","unstructured":"Ramos, M., Lao, Y., Eguiluz, C., Del Val, M. & Mart\u00ednez, I. Urokinase receptor-deficient mice mount an innate immune response to and clarify respiratory viruses as efficiently as wild-type mice. Virulence 6, 710\u2013715 (2015).","DOI":"10.1080\/21505594.2015.1057389"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07763-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:40:33Z","timestamp":1741066833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07763-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7763"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07763-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4635283\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.G., J.R., A. F-M., C.F.G., M.A.M.-A. are inventors of a patent application pertaining to the compounds utilized in this work (European Patent Application EP4227324A1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}